Navigation Links
Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
Date:8/4/2009

PARSIPPANY, N.J., Aug. 4 /PRNewswire/ -- Ferring Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved the trade name FIRMAGON(R) (degarelix for injection) for its prostate cancer treatment previously marketed under the generic name degarelix. FIRMAGON is a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for patients with advanced prostate cancer. Since initial market introduction under the generic name degarelix, FIRMAGON has been used by more than 3,000 patients to fight their prostate cancer.

"This treatment was in development by Ferring Pharmaceuticals in the U.S. and Europe for more than a decade," said Wayne Anderson, President and CEO of Ferring Pharmaceuticals Inc., USA. "We launched degarelix prior to receiving approval for its brand name in order to bring the medical community an effective alternative in the treatment of advanced prostate cancer without delay. We plan to continue our research in the area of urology and we expect to introduce additional treatment advances in the future."

FIRMAGON provides fast, long-term suppression of testosterone, a hormone that stimulates prostate cancer growth.(1-3) Phase III pivotal studies showed that FIRMAGON is as effective as leuprolide (Lupron Depot(R))* in reducing and sustaining castrate levels of testosterone.(1,2) Suppression of testosterone to castrate levels occurred significantly faster in patients receiving FIRMAGON than in those receiving leuprolide.(1,2) At Day 3 of treatment, the FIRMAGON group achieved a 90 percent decrease in median testosterone levels compared with the leuprolide group, which experienced a 65 percent increase in median testosterone levels, a statistically significant result. FIRMAGON was as effective as leuprolide in suppressing testosterone levels from Day 28 to the end of the study (Day 364), with 97.2 percent of the FIRMAGON patients maintain
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ferring Donates US$3 Million to the Royal Textile Academy of Bhutan
2. VA Transferring 85.4 Acres from North Chicago VA Medical Center
3. ALL: Boston Archdiocese Reportedly on Track for Abortion Referring Venture
4. Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program
5. Educating referring clinicians about advanced imaging leads to drop in imaging exams
6. Frost & Sullivan Accolade for Ferring Pharmaceuticals
7. Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
8. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
9. Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System
10. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
11. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... Providenciales, Turks and Caicos Islands, BWI (PRWEB) April 25, ... Providenciales International Airport (PLS) has celebrated three months of ... since reopening on January 5, 2015. , As ... phases, the interior of Providenciales airport was completely redesigned ... area has quickened up the process of getting out ...
(Date:4/25/2015)... April 25, 2015 On Friday, April ... RFID Journal’s annual Best Implementation Award. This award ... the best use of RFID technology to improve its ... the company that best demonstrates how RFID is delivering ... at RFID Journal Live! 2015 in San Diego, the ...
(Date:4/24/2015)... AK (PRWEB) April 24, 2015 As ... (#MOTMC2015) and the unique sacrifices of these young men ... for Service members, Veterans and their Families” presents a ... training is designed to gain a better understanding of ... health and wellness. For those – civilian and military ...
(Date:4/24/2015)... The 1975 have had an intense ... globe to theaters, festivals and TV performances. Now that they’ve ... their label, Dirty Hit Records, to provide clean drinking water ... launched Cadence & Cause website, this four-piece has ... and a signed photo card. Entries from this sweepstakes ...
(Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in Long-Term ... their exclusive agreement with LTC Solutions for All LLC ... partner. , Anchor has more than 18 years of ... associations, and is currently the designated advocate for the ... Insurance member benefit. , “I am very pleased to ...
Breaking Medicine News(10 mins):Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2
... simulation exhibition event ever held will feature top leaders from ... opening ceremonies of the Interservice/Industry Training, Simulation and Education Conference ... Army Training and Doctrine Command (TRADOC). Joining him will ... Martin Joint Strike Fighter Program. , ...
... Latina women who prefer speaking Spanish are more likely ... with their breast cancer treatment, according to a new ... Cancer Center. , Despite receiving similar treatment, Latina women ... report high levels of dissatisfaction and regret about their ...
... and healthcare information resource, today released the results ... increasing healthcare costs and more infrequent doctor visits. ... percent) indicated they are going to the doctor ... healthcare costs. In an additional question of 274 ...
... when given before birth, glucocorticoids tied to cognitive, motor ... News) -- Glucocorticoid drugs used to treat chronic lung ... and may cause cognitive and motor control problems even ... Washington University School of Medicine in St. Louis. , ...
... found little link between drinking and malignancies , , MONDAY, ... your chances of developing cancer after age 65, new ... lack of physical activity were among the usual suspects ... to the Duke University study. , The findings are ...
... a test would be especially useful for blacks, other high-risk ... someday be able to use five genetic markers to assess ... cancer, a new study suggests. , If reliable, these five ... patients, or men of any race with a family history ...
Cached Medicine News:Health News:Military, Industry Leaders to Speak at World's Largest Simulation Event 2Health News:Military, Industry Leaders to Speak at World's Largest Simulation Event 3Health News: More Than Half of Consumers Going to Doctors Less Due to Rising Healthcare Costs, According to checkMD Survey : 38 Percent Lack Adequate Employer Healthcare Coverage 2Health News: More Than Half of Consumers Going to Doctors Less Due to Rising Healthcare Costs, According to checkMD Survey : 38 Percent Lack Adequate Employer Healthcare Coverage 3Health News:Drugs to Treat Lung Damage in Preemies May Harm Brain 2Health News:Stay Upbeat, Exercise to Help Prevent Cancer in Old Age 2Health News:Gene Screen Might Predict Prostate Cancer 2
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/24/2015)... 2015 Hospira, Inc. (NYSE: ... biosimilar therapies, spoke about the importance of extrapolation in ... Association (EGA) annual European Biosimilars Group conference in ... announced the publication of a pivotal white paper titled, ... promise of biosimilars." Speaking at the ...
(Date:4/24/2015)... April 24, 2015  Blueprint Medicines today announced ... and potent inhibitor of fibroblast growth factor receptor ... of hepatocellular carcinoma (HCC) that are dependent on ... induced complete tumor regression in a subset of ... at the highest dose levels. These data will ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3
... of Beta Blockers May Have Long-Term BenefitsSAN FRANCISCO, ... a research breakthrough suggesting that, contrary to popular ... pressure may also bring relief to many asthma ... of the American Asthma Foundation (AAF), said, "Drugs ...
... VEGAS, Feb. 26 Tying a shoe, typing ... The mobility of our fingers and wrists can often be ... begins, and interferes with simple, everyday tasks. According to ... American Academy of Orthopaedic Surgeons (AAOS) ( http://www.aaos.org/ ...
Cached Medicine Technology:Research Finding Could Revolutionize Asthma Treatment 2Research Finding Could Revolutionize Asthma Treatment 3Research Finding Could Revolutionize Asthma Treatment 4Got Pain? 2Got Pain? 3Got Pain? 4
... Recently updated with a high ... the new Kowa Non Myd - ... quality, style and ease of use. ... comprehensive, easy to install VK-2 image ...
The quick access to diabetic screening, panoramic images of the retina including peripheral area are available by using easy, semi automatic guidance of peripheral fixation....
Measurement of progressive multi-focal lenses is fast and easy with the CLM-3100P auto-lensmeter. The data is represented in a simple to understand graphic display....
Autolensmeter with color 5.7 inch LCD screen and built in printer....
Medicine Products: